SCHEMBL8286370

SCHEMBL8286370

Cc1cc(Cl)c2c(=O)cc(Nc3cccc(F)c3)n(-c3cccc(F)c3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
LMNA P02545 6/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 4/20 0.39
PDE11A Q9HCR9 1/20 0.39
ABCC1 P33527 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
TP53 P04637 2/20 0.38
CHRNA7 P36544 1/20 0.38
P2RX3 P56373 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HTT P42858 2/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
POLB P06746 1/20 0.36
SLC2A1 P11166 1/20 0.36
MEN1 O00255 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871846 0.84 PDE11A (0.49) LMNASMN1; SMN2MAPTPDE11ATP53
SCHEMBL8286456 0.84 L3MBTL1 (0.44) L3MBTL1TAAR1LMNASMN1; SMN2MAPT
SCHEMBL8287872 0.77 MAT2A (0.47) L3MBTL1TAAR1LMNASMN1; SMN2MAPT
SCHEMBL8287801 0.77 ALDH1A2 (0.37) L3MBTL1TAAR1SMN1; SMN2MAPTPDE11A
SCHEMBL8285301 0.76 L3MBTL1 (0.41) L3MBTL1TAAR1LMNASMN1; SMN2MAPT
SCHEMBL8287198 0.76 L3MBTL1 (0.41) L3MBTL1TAAR1LMNASMN1; SMN2MAPT
SCHEMBL8287868 0.74 PDE11A (0.47) L3MBTL1TAAR1LMNAMAPTPDE11A
SCHEMBL5871658 0.74 PDE11A (0.48) LMNASMN1; SMN2MAPTPDE11AKDM4E
SCHEMBL8285163 0.74 POLB (0.50) LMNASMN1; SMN2MAPTPDE11ATP53
SCHEMBL8286378 0.73 PDE11A (0.49) LMNAMAPTPDE11ATP53RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed